论文信息 - One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study - 字舞流文

One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study

A. Grauer | J. Adachi | P. Ebeling | E. Lewiecki | R. Dinavahi | C. Libanati | A. Miyauchi | E. Gielen | M. Lazaretti-Castro | C. E. Milmont | Cassandra E. Milmont